<?xml version="1.0" encoding="UTF-8"?>
<p>Severe and fatal MPV disease can occur among immunocompromised individuals, including solid organ and stem cell transplant recipients, HIV-infected persons, and chemotherapy patients [
 <xref ref-type="bibr" rid="CR268">268</xref>â€“
 <xref ref-type="bibr" rid="CR275">275</xref>]. MPV is associated with morbidity and mortality in adults with hematologic malignancies and stem cell transplant; [
 <xref ref-type="bibr" rid="CR270">270</xref>, 
 <xref ref-type="bibr" rid="CR276">276</xref>] MPV was detected in bronchoalveolar lavage specimens from 5/163 (3 %) episodes of acute respiratory infection in stem cell transplant recipients, and four died [
 <xref ref-type="bibr" rid="CR270">270</xref>]. HIV-positive South African children with MPV were significantly more likely to receive a diagnosis of pneumonia and experience longer hospitalization, lower mean oxygen saturation, and bacteremia; further, HIV-positive children were fivefold more likely to be infected with MPV than HIV-negative children [
 <xref ref-type="bibr" rid="CR242">242</xref>].
</p>
